Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients (POSOVIR).
Phase of Trial: Phase IV
Latest Information Update: 27 Oct 2010
At a glance
- Drugs Nevirapine (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms POSOVIR
- 10 Jun 2017 Biomarkers information updated
- 10 Jul 2007 New trial record.